SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,656.09 286.98
( 0.37%)

Global Indices

Nasdaq

53,439.07 141.06
(0.26%)

Dow Jones

7,673.94 -21.43
(-0.28%)

Hang Seng

65,802.43 274.34
(0.42%)

Nikkei 225

10,884.15 29.83
(0.27%)

Forex

USD-INR

95.63 -0.04
(-0.04%)

EUR-INR

111.66 -0.10
(-0.09%)

GBP-INR

130.46 0.10
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

63.3529756

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

40.85

3385.04

EPS(TTM)

Face Value()

Div & Yield %

7.4

1.77

Back

LTM consolidated net profit rises 16.92% in the June 2026 quarter

Jul 13,2026

Net profit of LTM rose 16.92% to Rs 1466.30 crore in the quarter ended June 2026 as against Rs 1254.10 crore during the previous quarter ended June 2025. Sales rose 17.96% to Rs 11608.00 crore in the quarter ended June 2026 as against Rs 9840.60 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	11608.00	9840.60	18
OPM %	17.75	16.76	-
PBDT	2239.70	1969.10	14
PBT	1978.40	1726.20	15
NP	1466.30	1254.10	17

77,656.09 286.98 ( 0.37%)

53,439.07 141.06 (0.26%)

7,673.94 -21.43 (-0.28%)

65,802.43 274.34 (0.42%)

10,884.15 29.83 (0.27%)

95.63 -0.04 (-0.04%)

111.66 -0.10 (-0.09%)

130.46 0.10 (0.08%)

0.60 0.00 (-0.21%)